| Aldeyra Therapeutics, Inc. (ALDX) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | |
| Balance Sheet Date | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | |
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | Q1-FY2014 | |
| Operating Cash Flow | (5,299,345$) | (7,021,416$) | (8,555,222$) | (12,469,699$) | (12,036,845$) | (7,974,917$) | (13,224,298$) | (9,972,687$) | 500,440$ | (8,024,914$) | (13,357,836$) | (9,443,818$) | (11,231,177$) | (12,574,218$) | (19,958,593$) | (12,873,199$) | (11,577,699$) | (8,434,100$) | (9,072,367$) | (13,471,741$) | (8,317,197$) | (6,237,452$) | (7,579,054$) | (15,359,752$) | (11,226,323$) | (8,315,046$) | (12,810,879$) | (12,631,978$) | (7,968,175$) | (7,688,672$) | (7,954,593$) | (5,018,517$) | (4,705,604$) | ||||||||||||||||
| Investing Cash Flow | 16,000,000$ | 25,000,000$ | (554,126$) | 7,290,414$ | (1,563,871$) | 5,262,615$ | (18,237,879$) | (30,376,620$) | 0$ | 0$ | 0$ | 30,000,000$ | 27,000,000$ | 19,015,976$ | (17,938,720$) | (58,031,786$) | 0$ | 0$ | 0$ | (7,806$) | 0$ | 5,500,000$ | 17,300,000$ | 6,223,910$ | (4,285,156$) | 5,675,527$ | 7,922,026$ | 9,164,454$ | (28,972,362$) | (21,302$) | 4,801,481$ | (8,109,975$) | (3,627,932$) | ||||||||||||||||
| Purchases of Property and Equipment | 0$ | 0$ | 0$ | 16,317$ | 0$ | 0$ | 0$ | 7,806$ | 0$ | 0$ | 4,604$ | 4,925$ | 14,584$ | 47,619$ | 61,757$ | 139,006$ | 13,167$ | 0$ | 0$ | 11,592$ | 0$ | 0$ | 2,576$ | 9,234$ | 0$ | 54,243$ | 30,435$ | 1,441$ | 7,955$ | ||||||||||||||||||||
| Financing Cash Flow | 0$ | 120,746$ | 0$ | 1,002,810$ | 7,779$ | (197,392$) | 0$ | 18,191$ | (1,012,312$) | (315,759$) | 5,292$ | 52,559$ | 0$ | 1,196,768$ | 0$ | 23,324$ | 0$ | 63,778$ | 120,368,998$ | 74,063,615$ | 1$ | 26,224,125$ | 12,424,917$ | 3,252,983$ | 8,333,106$ | 14,844,158$ | (9,138$) | 407,607$ | 66,289,357$ | 1,112,952$ | 4,093,316$ | 47,980$ | 26,827,643$ | ||||||||||||||||
| End Cash Position | 70,041,254$ | 59,340,599$ | 41,241,269$ | 50,350,617$ | 54,527,092$ | 68,120,029$ | 71,029,723$ | 102,491,900$ | 142,823,016$ | 143,334,888$ | 151,675,561$ | 165,028,105$ | 144,419,364$ | 128,650,541$ | 121,012,015$ | 158,909,328$ | 229,790,989$ | 241,368,688$ | 249,739,010$ | 138,442,379$ | 77,858,311$ | 86,175,507$ | 60,688,834$ | 38,542,971$ | 44,425,830$ | 51,604,203$ | 39,399,564$ | 44,297,555$ | 47,357,472$ | 18,008,652$ | 24,605,674$ | 20,963,541$ | 20,023,337$ | 33,103,849$ | 14,609,742$ | 12,015,061$ | 12,015,061$ | 14,568,508$ | 17,607,522$ | 14,648,866$ | 14,648,866$ | 30,618,365$ | 33,569,784$ | 15,721,097$ | 8,527,304$ | 10,142,137$ | 11,535,788$ | 2,145,621$ | |
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (5,299,345$) | (7,021,416$) | (8,555,222$) | (12,469,699$) | (12,036,845$) | (7,974,917$) | (13,224,298$) | (9,972,687$) | 500,440$ | (8,024,914$) | (13,357,836$) | (9,443,818$) | (11,231,177$) | (12,574,218$) | (19,958,593$) | (12,889,516$) | (11,577,699$) | (8,434,100$) | (9,072,367$) | (13,479,547$) | (8,317,197$) | (6,237,452$) | (7,579,054$) | (15,359,752$) | (11,226,323$) | (8,315,046$) | (12,815,483$) | (12,636,903$) | (7,982,759$) | (7,736,291$) | (8,093,599$) | (5,031,684$) | (4,705,604$) | ||||||||||||||||